GASVAC

Description

Ranitidine Syrup, with a composition of 150 mg of ranitidine per dose, is a medication that belongs to the class of histamine H2 receptor blockers. This medication works by reducing the production of stomach acid, thereby alleviating symptoms associated with excessive acid production in the stomach.

Ranitidine is a type of antihistamine that blocks the release of stomach acid. It is used to treat stomach or intestinal ulcers. It can relieve ulcer pain and discomfort, and the heartburn from acid reflux.

Headache, constipation, easy bruising, & diarrhea

As prescribed by doctor

Ranitidine is a histamine H2 receptor blocker that reduces the amount of acid made in the stomach. It relieves acid-related indigestion and heartburn.

• 1. Ranitidine may decrease the excretion rate of Abacavir which could result in a higher serum level.


• 2. The serum concentration of Ranitidine can be increased when it is combined with Abametapir.


• 3. The metabolism of Ranitidine can be increased when combined with Abatacept.


• 4. The serum concentration of Ranitidine can be increased when it is combined with Abiraterone.


• 5. The metabolism of Acebutolol can be decreased when combined with Ranitidine.

It is a well-tolerated medicine and provides relief for a long time. Some healthy tips to prevent acidity from happening: Avoid excessive intake of carbonated beverages/soft drinks, citrus juices, fried food, caffeinated beverages like tea and coffee. Avoid alcohol and smoking. Avoid eating late at night or before bedtime. Inform your doctor if you get watery diarrhea, fever or stomach pain that does not go away.

If you have missed giving any dose of this medicine, then give it as soon as you remember. If it's already time for the next dose then skip the missed dose and follow the regular dosing schedule. Follow the dosing schedule regularly & take this medicine at regular intervals.

• 1. Mauran A, Goze T, Abadie D, Bondon-Guitton E, Chevrel P, Schmitt L, Montastruc JL, Montastruc F: Mania associated with ranitidine: a case report and review of literature. Fundam Clin Pharmacol. 2016 Aug;30(4):294-6. doi: 10.1111/fcp.12201. Epub 2016 May 5. [Article]
• 2. Grant SM, Langtry HD, Brogden RN: Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. Drugs. 1989 Jun;37(6):801-70. doi: 10.2165/00003495-198937060-00003. [Article]
• 3. Pettit M: Treatment of gastroesophageal reflux disease. Pharm World Sci. 2005 Dec;27(6):432-5. doi: 10.1007/s11096-005-4798-7. [Article]
• 4. Badillo R, Francis D: Diagnosis and treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther. 2014 Aug 6;5(3):105-12. doi: 10.4292/wjgpt.v5.i3.105. [Article]"